Thông tin tài liệu
CURRENT TRENDS IN
ATHEROGENESIS
Edited by Rita Rezzani
Current Trends in Atherogenesis
http://dx.doi.org/10.5772/56246
Edited by Rita Rezzani
Contributors
Agius, McGillion, Carlos Teixeira Brandt, Alexander Orekhov, Katsuri Ranganna, Ilse Van Brussel, Luigi Fabrizio Rodella,
Gaia Favero, Robert Lawrence Taylor Jr., Janet Anderson, Samuel Smith, Alessandra Stacchiotti, Rita Rezzani, Zlata
Flegar-Mestric, Sonja Perkov, Mirjana Marijana Kardum Paro, Vinko Vidjak, Martine Glorian
Published by InTech
Janeza Trdine 9, 51000 Rijeka, Croatia
Copyright © 2013 InTech
All chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to
download, copy and build upon published articles even for commercial purposes, as long as the author and publisher
are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work
has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they
are the author, and to make other personal use of the work. Any republication, referencing or personal use of the
work must explicitly identify the original source.
Notice
Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those
of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published
chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the
use of any materials, instructions, methods or ideas contained in the book.
Publishing Process Manager Dragana Manestar
Technical Editor InTech DTP team
Cover InTech Design team
First published February, 2013
Printed in Croatia
A free online edition of this book is available at www.intechopen.com
Additional hard copies can be obtained from orders@intechopen.com
Current Trends in Atherogenesis , Edited by Rita Rezzani
p. cm.
ISBN 978-953-51-1011-8
free online editions of InTech
Books and Journals can be found at
www.intechopen.com
Contents
Preface VII
Chapter 1 Atherosclerosis and Current Anti-Oxidant Strategies for
Atheroprotection 1
Luigi Fabrizio Rodella and Gaia Favero
Chapter 2 Endoplasmic Reticulum Stress in the Endothelium: A
Contribution to Athero-Susceptibility 27
Alessandra Stacchiotti, Gaia Favero and Rita Rezzani
Chapter 3 Dendritic Cells in Atherogenesis: From Immune Shapers to
Therapeutic Targets 55
Ilse Van Brussel, Hidde Bult, Wim Martinet, Guido R.Y. De Meyer
and Dorien M. Schrijvers
Chapter 4 Atherogenesis: Diseases that May Affect the Natural History
“Schistosomiasis and HIV Infection” 81
Carlos Teixeira Brandt, Emanuelle Tenório A. M. Godoi, André
Valença, Guilherme Veras Mascena and Jocelene Tenório A. M.
Godoi
Chapter 5 The Evaluation of New Biomarkers of Inflammation and
Angiogenesis in Peripheral Arterial Disease 97
Sonja Perkov, Mirjana Mariana Kardum Paro, Vinko Vidjak and Zlata
Flegar-Meštrić
Chapter 6 The Role of Cyclic 3’-5’ Adenosine Monophosphate (cAMP) in
Differentiated and Trans-Differentiated Vascular Smooth
Muscle Cells 121
Martine Glorian and Isabelle Limon
Chapter 7 MicroRNAome of Vascular Smooth Muscle Cells: Potential for
MicroRNA-Based Vascular Therapies 147
Kasturi Ranganna, Omana P. Mathew, Shirlette G. Milton and
Barbara E. Hayes
Chapter 8 Atherosclerosis-Susceptible and Atherosclerosis-Resistant
Pigeon Aortic Smooth Muscle Cells Express Different Genes and
Proteins in vitro 165
J. L. Anderson, S. C. Smith and R. L. Taylor Jr.
Chapter 9 Use of Natural Products for Direct
Anti-Atherosclerotic Therapy 187
Alexander N. Orekhov, Igor A. Sobenin, Alexandra A. Melnichenko,
Veronika A. Myasoedova and Yuri V. Bobryshev
Chapter 10 Self-Management Training for Chronic Stable Angina: Theory,
Process, and Outcomes 219
M.H. McGillion, S. O’Keefe-McCarthy and S.L. Carroll
Chapter 11 Attributes of Hypoxic Preconditioning Determine the
Complicating Atherogenesis of Plaques 237
Lawrence M Agius
ContentsVI
Preface
Cardiovascular diseases and atherogenesis have been and still are an important topic many
scientists are working on.
In the 16th century, Leonardo da Vinci had described “The narrowing of the passage of
blood vessels, thickening of the coats of these vessels and hardening of arteries”. This is the
first documentation of atherosclerosis, but today our understanding of atherogenesis as a
process of a chronic inflammatory disease has been updated by many mechanisms such as
hypercholesterolemia, dysfunction of endothelial cells, oxidation of lipoproteins and espe‐
cially oxidative stress. In particular, the endothelium is responsible for the regulation of vas‐
cular tone, the exchange of plasma and cell biomolecules, inflammation, lipid metabolism
and modulation of fibrinolysis and coagulation. Endothelial cell disruption, morphological
abnormalities in size and shape, susceptibility to apoptosis and abnormal release of endo‐
thelial cell-derived factors are strictly implicated in the pathogenetic mechanisms of cardio‐
vascular diseases. Growing evidence indicates that chronic and acute overproduction of
oxidative stress alters endothelial cells as pivotal early event in atherogenesis.
It is important to remember that drugs intake, such as statins, life style control for regulating
fat intake and exercise activity must be monitored for improving cardiovascular disease in‐
cidence. In recent years a novel topic regarding antioxidant properties of some natural sub‐
stances seems to be very important for decreasing certain problems related to cardiovascular
diseases and atherogenesis.
This book presents the state of the art of the antioxidants in the clinical and experimental
approaches in order to bring better understanding of the mechanisms and useful therapies
for these diseases. We hope that it can indicate new “current
trends” for identifying new
aspects regarding this scientific problem involving not only anatomical and functional, but
also clinical questions.
Dr. Rita Rezzani
University of Brescia
Italy
Chapter 1
Atherosclerosis and Current Anti-Oxidant
Strategies for Atheroprotection
Luigi Fabrizio Rodella and Gaia Favero
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/53035
1. Introduction
Cardiovascular diseases (CVDs) remain the leading cause of death in modern societies. The
primary cause of dramatic clinical events of CVDs, such as unstable angina, myocardial in‐
farction and stroke, is the atherosclerotic process [1,2,3].
The pathophysiological mechanisms of atherosclerosis are complicated and the integrated
picture of the disease process is not yet complete, so currently is largely investigated. It is
widely recognized that oxidative stress, lipid deposition, inflammation, Vascular smooth
muscle cells (VSMCs) differentiation and endothelial dysfunction play a critical role in the
formation, progression and eventually rupture of the atherosclerotic plaque [4]. Multiple risk
factors have been associated with the development of atherosclerotic lesions; these include
diabetes mellitus, hypertension, obesity and tobacco smoking. The risk factors are influenced
by genetic predisposition, but also by environmental factors, particularly diet. Moreover, ag‐
ing promotes physiological changes, such as oxidative stress, inflammation and endothelial
dysfunction strictly associated with the pathophysiology of atherosclerosis [5].
The common belief that signs of atherosclerosis and CVDs are clinically relevant only dur‐
ing adult and elderly age is gradually changing, increasing evidence supports that athero‐
genesis is initiated in childhood [6].
Low-density lipoproteins (LDL) are crucial to the development of atherosclerotic lesions,
whereas high-density lipoproteins (HDL) are inhibitors of the process, primarily through
the process of reverse cholesterol transport [4,7]. Dysfunctional lipid homeostasis plays a
central role in the initiation and progression of atherosclerotic lesions. Oxidized-LDL (ox-
LDL) induces endothelial dysfunction with focal inflammation which causes increased ex‐
pression of atherogenic signaling molecules that promote the adhesion of monocytes and T
© 2013 Fabrizio Rodella and Favero; licensee InTech. This is an open access article distributed under the terms
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
lymphocytes to the arterial endothelium and their penetration into the intima. Early stages
of plaque development involve endothelial activation induced by inflammatory cytokines,
ox-LDL and/or changes in endothelial shear stress [8,9]. The monocyte-derived macrophag‐
es, by taking up ox-LDL, become foam cells, which are typical cellular elements of the fatty
streak, the earliest detectable atherosclerotic lesion [10].
After initial injury, different cell types, including endothelial cells, platelets and inflammato‐
ry cells release growth factors and cytokines that induce multiple effects: oxidative stress,
inflammation, VSMCs differentiation from the contractile state to the active synthetic state
and then proliferate and migrate in the subendothelial space [11,12]. Inflammatory cell accu‐
mulation, migration and proliferation of VSMCs, as well as the formation of fibrous tissue,
lead to the enlargement and restructuring of the lesion, with the formation of an evident fi‐
brous cap and other vascular morphological changes [2,13]. Atherosclerotic plaques result
from the progressive accumulation of cholesterol and lipids in oxidized forms, extracellular
matrix material and inflammatory cells [14]. In fact, atherosclerosis manifests itself histologi‐
cally as an arterial lesions known as plaques, which have been extensively characterized:
plaques contain a central lipid core that is most often hypocellular and may include crystals
of cholesterol that have formed in the foam cells. The lipid core is separated from the arterial
lumen by a fibrous cap and myeloproliferative tissue that consists of extracellular matrix
and VSMCs. Advanced lesions can grow sufficiently large to block blood flow and so devel‐
op an acute occlusion due to the formation of thrombus or blood clot resulting in the impor‐
tant and severe cardiovascular clinical events [2,10].
Figure 1. Main vascular alterations observed during atherogenesis. LDL: low density lipoprotein; HDL: high density lip‐
oprotein.
Current Trends in Atherogenesis2
[...]... epigallocatechin gallate, being the most abundant catechin (48–55%), followed by epi‐ 11 12 Current Trends in Atherogenesis gallocatechin (9–12%), epicatechin gallate (9–12%) and epicatechin (5–7%) [42] The catechin content of green tea depends on several factors including how the leaves are processed be‐ fore drying, preparation of the infusion and decaffeination, as well as the form in which it is... is distributed in the market (instant preparations, iced and ready-to-drink teas have been shown to contain fewer catechins) [43] When tea leaves are rolled or broken during indus‐ try manufacture, catechins come in contact with polyphenol oxidase, resulting in their oxi‐ dation and the formation of flavanol dimers and polymers known as theaflavins and thearubigins [44] Tea leaves destined to become... requirement of vitamin C and is high in polyphenol compounds The pomegranate plant contains alkaloids, 13 14 Current Trends in Atherogenesis mannite, ellagic acid and gallic acid and the bark and rind contain various tannins The pol‐ yphenols in pomegranate are believed to provide the anti-oxidant activity and protect LDL against cell-mediated oxidation directly by interaction with the LDL [49] In fact, the... may contain aflatoxin, a potent hepatocarcinogen; thus, it should be used cautiously by patients who have hepatic dysfunction or who are taking other hepatotoxic agents Pomegranate may also increase the risk for rhabdomyolysis during statin therapy, as a result of intestinal CYP3A4 inhibition and increased absorption of active drugs [49] 10 Wine The last two decades have seen renewed interest in the... when added in combination [74] Moreover, 6-hydroxymelatonin, the main in vivo metabolite of melatonin, and its precursor, N-acetyl-5-hydroxytryptamine, were potent in reducing in vitro LDL peroxidation The abili‐ ty of the parent molecule melatonin as well as its metabolites to function in radical detoxifi‐ cation greatly increases its ability to limit oxidative abuse at many levels within cells [9]... vita‐ min E in hypercholesterolemic patients and/or chronic smokers increase levels of autoanti‐ bodies against ox-LDL There is also a quite convincing evidence from in vitro studies that vitamin C strongly inhibits LDL oxidation [27] It is important to underline that there are no definite recommendations on the dose and du‐ ration of supplementation with vitamins in human Although, high dietary intake... Toll-like receptors (TLRs), that in turn at‐ tract leukocytes adhesion in the intima layer Mainly TLR 2 and TLR4 are active in mouse in the progression of atherosclerosis and their signals stimulate a downstream adaptor mole‐ cule, called Toll/IL-1 receptor domain-related adaptor protein that induces interferon or TRIF Indeed also in human vascular tree, by immunostaining and mRNA survey TLR2 and TLR4... also affect indirectly the redox status by increasing the capacity of en‐ dogenous anti-oxidants or by inhibiting enzymatic systems involved in ROS formation [36] The free-radical scavenging activity of many polyphenols has been reported to be much stronger than that of vitamin C, vitamin E or glutathione, the major anti-oxidants present in the body In spite of their potent protective effects in the development... interest in the health benefits of wine, as documented by increasing research and several epidemiologic observations showing that moderate wine drinkers have lower cardiovascular mortality rates than heavy drinkers or teetotalers Most of the beneficial effects of wine against CVDs have been attributed to the presence in red wine of resveratrol and other polyphenols Wines contain polyphenolic compounds that... one hand, due to its richness in oleic acid and, on the other hand, due to its minor components of the olive oil particularly 15 16 Current Trends in Atherogenesis the phenolic compounds The phenolic content in virgin olive oil could reduce the lipid oxi‐ dation and inhibit platelet-induced aggregation [53] Moreover, olive oil minor components have also been involved in the anti-oxidant activity of . CURRENT TRENDS IN
ATHEROGENESIS
Edited by Rita Rezzani
Current Trends in Atherogenesis
http://dx.doi.org/10.5772/56246
Edited. radical scaveng‐
ing activity [27,40].
Current Trends in Atherogenesis1 0
Since the evidence of therapeutic effects of dietary flavinoids continues to accumulate,
Ngày đăng: 23/03/2014, 10:20
Xem thêm: CURRENT TRENDS IN ATHEROGENESIS pptx, CURRENT TRENDS IN ATHEROGENESIS pptx